CSIMarket
 
Healthcare Sector

Biotechnology & Pharmaceuticals Industry  




Data by Company within Biotechnology & Pharmaceuticals Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Amgen Inc $ 145,687 $ 28,190 $ 6,717 24,200
Gilead Sciences Inc $ 92,226 $ 27,116 $ 5,613 14,400
Seagen Inc $ 43,034 $ 2,300 $ -750 2,700
Moderna Inc $ 39,704 $ 6,848 $ -4,714 2,700
Biogen Inc $ 31,963 $ 9,836 $ 1,162 9,610
Argenx se $ 19,661 $ 856 $ -710 -
Neurocrine Biosciences Inc $ 14,062 $ 1,887 $ 250 1,000
Bio techne Corp $ 11,608 $ 1,143 $ 224 3,000
Repligen Corp $ 10,786 $ 670 $ 116 1,170
Qiagen N v $ 10,156 $ 1,901 $ 341 5,700
Exelixis Inc $ 7,345 $ 1,830 $ 465 566
Vaxcyte Inc $ 7,086 - $ -300 -
Crispr Therapeutics Ag $ 5,793 $ 170 $ -354 -
Abcam Plc $ 5,511 - $ 0 -
Halozyme Therapeutics Inc $ 5,479 $ 829 $ 282 3,011
Krystal Biotech Inc $ 4,849 - $ 11 -
Immunovant Inc $ 4,412 - $ -243 -
Orchard Therapeutics Plc $ 3,814 $ 22 $ -73 -
Revolution Medicines Inc $ 3,477 $ 30 $ -331 -
Arcellx Inc $ 3,421 - $ -130 -
Iovance Biotherapeutics Inc $ 3,268 - $ -444 -
Springworks Therapeutics Inc $ 3,174 - $ -348 -
Immunocore Holdings Plc $ 2,976 - $ 0 -
Apogee Therapeutics inc $ 2,817 - $ 0 -
Beam Therapeutics Inc $ 2,798 $ 82 $ -314 -
Denali Therapeutics Inc $ 2,758 $ 341 $ 0 340
Jasper Therapeutics Inc $ 2,752 - $ -61 -
Immunitybio inc $ 2,557 $ 1 $ -459 -
Recursion Pharmaceuticals Inc $ 2,330 $ 45 $ -328 -
Outlook Therapeutics Inc $ 2,145 - $ -51 -
Ginkgo Bioworks Holdings Inc $ 2,107 $ 315 $ -855 -
Kymera Therapeutics Inc $ 2,096 $ 67 $ -103 -
Vericel Corporation $ 2,012 $ 198 $ -3 -
Twist Bioscience Corporation $ 1,934 $ 262 $ -206 750
Adaptimmune Therapeutics Plc $ 1,873 $ 66 $ -114 -
Mesoblast Ltd $ 1,796 $ 8 $ -82 -
Sana Biotechnology Inc $ 1,780 - $ -280 -
Ambrx Biopharma Inc $ 1,743 $ 9 $ -134 -
Inhibrx Inc $ 1,650 $ 2 $ -241 -
Instil Bio Inc $ 1,614 $ 1 $ -197 -
Opthea Limited $ 1,527 $ 0 $ -143 -
Vir Biotechnology Inc $ 1,442 $ 86 $ -615 -
4d Molecular Therapeutics Inc $ 1,332 $ 22 $ -96 -
Adma Biologics Inc $ 1,301 $ 258 $ -28 256
Precision Biosciences Inc $ 1,298 $ 52 $ -74 -
Scholar Rock Holding Corp $ 1,165 $ 47 $ -159 -
Autolus Therapeutics Plc $ 1,013 $ 0 $ -149 -
Curis Inc $ 996 $ 10 $ -47 -
Regenxbio Inc $ 974 $ 99 $ -261 300
Relay Therapeutics Inc $ 972 $ 26 $ -327 -
Biocryst Pharmaceuticals Inc $ 960 $ 331 $ -227 192
Tarsus Pharmaceuticals Inc $ 929 $ 17 $ -136 -
Valneva Se $ 891 $ 390 $ -82 550
Cabaletta Bio Inc $ 833 - $ -62 -
Icosavax Inc $ 766 $ 1 $ -97 -
Vectivbio Holding Ag $ 745 $ 27 $ -94 -
Fate Therapeutics Inc $ 738 $ 106 $ -173 208
Aerie Pharmaceuticals Inc $ 729 $ 214 $ -37 259
Neumora Therapeutics Inc $ 705 - $ 0 -
Hillevax Inc $ 703 - $ -108 -
Fusion Pharmaceuticals Inc $ 690 $ 2 $ 84 -
Cullinan Oncology Inc $ 681 - $ -157 2
Tscan Therapeutics Inc $ 675 $ 17 $ -88 -
Allogene Therapeutics inc $ 667 $ 0 $ -340 -
Prime Medicine Inc $ 651 - $ 0 -
Editas Medicine Inc $ 617 $ 78 $ -153 -
Replimune Group Inc $ 568 - $ -210 -
Novavax inc $ 533 $ 984 $ -545 370
Alector Inc $ 514 $ 96 $ -141 155
Mymetics Corporation $ 486 $ 1 $ -14 -
Adaptive Biotechnologies Corporation $ 469 $ 180 $ -196 645
C4 Therapeutics Inc $ 443 $ 21 $ -132 -
Voyager Therapeutics Inc $ 413 $ 250 $ 132 -
Caribou Biosciences Inc $ 397 $ 34 $ -102 -
Invivyd Inc $ 395 - $ -170 -
Surrozen Inc $ 390 - $ -35 -
Iteos Therapeutics Inc $ 387 $ 128 $ -62 97
Freeline Therapeutics Holdings Plc $ 384 - $ -140 -
Tenaya Therapeutics Inc $ 368 - $ -128 -
Meiragtx Holdings Plc $ 358 $ 14 $ -84 -
Humacyte Inc $ 335 - $ -89 -
Monte Rosa Therapeutics Inc $ 319 - $ -133 -
Kodiak Sciences Inc $ 307 - $ -271 -
Century Therapeutics inc $ 301 $ 2 $ -137 -
Oyster Point Pharma Inc $ 300 $ 20 $ -235 -
Poseida Therapeutics Inc $ 296 $ 52 $ -132 -
Compass Therapeutics Inc $ 292 - $ -41 -
Sab Biotherapeutics Inc $ 289 $ 4 $ -27 -
Taysha Gene Therapies Inc $ 289 $ 14 $ -215 -
Sophia Genetics Sa $ 289 $ 62 $ -79 -
Ocugen Inc $ 277 - $ -76 -
Aura Biosciences Inc $ 275 - $ -71 -
Gritstone Bio Inc $ 275 $ 10 $ -71 -
Solid Biosciences Inc $ 262 $ 15 $ -91 -
Sutro Biopharma Inc $ 249 $ 49 $ -172 -
Compugen Ltd $ 236 $ 8 $ -34 -
Eiger Biopharmaceuticals Inc $ 228 $ 15 $ -87 -
Checkmate Pharmaceuticals Inc $ 227 - $ -63 -
Acumen Pharmaceuticals Inc $ 227 - $ -49 -
Lineage Cell Therapeutics Inc $ 226 $ 9 $ -23 -
Cardiff Oncology inc $ 225 $ 3 $ -23 -
Agenus Inc $ 210 $ 101 $ -283 -
Black Diamond Therapeutics Inc $ 210 - $ -82 -
Coherus Biosciences inc $ 209 $ 257 $ -238 650
Innate Pharma Sa $ 201 $ 65 $ -65 -
Omega Therapeutics Inc $ 200 $ 3 $ -108 -
La Jolla Pharmaceutical Company $ 200 $ 46 $ 4 -
Inmune Bio Inc $ 199 $ 0 $ -27 -
Scilex Holding Company $ 192 $ 71 $ -117 -
Graphite Bio Inc $ 191 - $ -126 -
Tourmaline Bio Inc $ 185 - $ -63 -
X4 Pharmaceuticals Inc $ 183 - $ -111 -
Apeiron Capital Investment Corp $ 180 - $ 7 -
Genfit S a $ 174 $ 30 $ -27 194
Adverum Biotechnologies Inc $ 172 $ 2 $ -126 -
Xtant Medical Holdings Inc $ 157 $ 77 $ 3 -
Vaxart Inc $ 156 $ 7 $ -82 -
Bluebird Bio Inc $ 155 $ 22 $ -91 -
Elevation Oncology inc $ 150 - $ -46 -
Zura Bio Limited $ 150 - $ -61 -
Titan Pharmaceuticals Inc $ 139 $ 2 $ -6 -
Sangamo Therapeutics Inc $ 136 $ 176 $ -258 411
Vor Biopharma Inc $ 130 - $ -116 -
Vigil Neuroscience Inc $ 130 - $ -79 -
Armata Pharmaceuticals Inc $ 130 $ 4 $ -60 -
Molecular Partners Ag $ 130 $ 7 $ -62 -
Protalix Biotherapeutics inc $ 123 $ 65 $ 8 -
Bioatla Inc $ 117 - $ -124 -
Atyr Pharma Inc $ 113 $ 10 $ -43 -
Athira Pharma Inc $ 100 - $ -121 -
Cel sci Corporation $ 97 - $ -31 -
Jounce Therapeutics inc $ 97 $ 148 $ 0 125
Cardiol Therapeutics inc $ 95 - $ 0 -
Miromatrix Medical inc $ 93 $ 1 $ -32 -
Allovir Inc $ 89 - $ -169 -
Prokidney Corp $ 87 - $ -222 -
Zivo Bioscience Inc $ 84 - $ -8 2
Passage Bio inc $ 82 - $ -102 -
Dbv Technologies S a $ 76 $ 16 $ -73 -
Champions Oncology Inc $ 74 $ 49 $ -10 -
Genenta Science S p a $ 71 - $ -9 -
Evaxion Biotech A $ 71 - $ -23 -
Logicbio Therapeutics Inc $ 68 $ 11 $ -27 -
Ikena Oncology Inc $ 68 $ 14 $ -63 -
Atara Biotherapeutics Inc $ 66 $ 14 $ -290 -
Intensity Therapeutics Inc $ 66 - $ 0 -
Phoenix Biotech Acquisition Corp $ 65 - $ -3 -
Surface Oncology Inc $ 65 $ 31 $ -93 -
Semper Paratus Acquisition Corporation $ 63 - $ 4 -
Tcr2 Therapeutics Inc $ 62 - $ -163 -
Cidara Therapeutics Inc $ 62 $ 41 $ -28 -
Elutia inc $ 60 $ 35 $ -38 -
Redwoods Acquisition Corp $ 58 - $ 5 -
Avrobio Inc $ 58 - $ -4 -
Turnstone Biologics Corp $ 58 - $ 0 -
Renovacor Inc $ 56 - $ -4 -
Cognition Therapeutics inc $ 55 - $ -23 -
Greenlight Biosciences Holdings Pbc $ 45 $ 10 $ -157 -
Candel Therapeutics Inc $ 43 $ 0 $ -32 -
Dyadic International Inc $ 43 - $ 2,482 84
Achilles Therapeutics Plc $ 43 - $ -71 -
Protara Therapeutics Inc $ 42 - $ -69 -
Pluri Inc $ 41 $ 0 $ -24 -
Aligos Therapeutics Inc $ 40 $ 16 $ -82 -
Gamida Cell Ltd $ 40 - $ 79 -
Entera Bio Ltd $ 39 - $ 9 -
Estrella Immunopharma Inc $ 39 - $ -4 -
In8bio Inc $ 36 - $ -30 -
Mink Therapeutics Inc $ 31 - $ -25 -
Axcella Health Inc $ 30 - $ -48 -
Cyclo Therapeutics Inc $ 27 $ 1 $ -20 -
Nkgen Biotech Inc $ 26 - $ -38 -
Applied Genetic Technologies Corporation $ 26 $ 42 $ -70 -
Lexeo Therapeutics Inc $ 25 - $ 0 -
Cargo Therapeutics Inc $ 23 - $ 0 -
Erytech Pharma S a $ 18 - $ -60 -
Pharmacyte Biotech Inc $ 17 - $ -2 -
Senti Biosciences Inc $ 17 $ 4 $ -82 -
Aim Immunotech Inc $ 16 - $ -22 -
Acorda Therapeutics Inc $ 15 $ 111 $ -16 327
Brainstorm Cell Therapeutics inc $ 15 - $ -17 -
Tracon Pharmaceuticals Inc $ 14 $ 11 $ -11 -
Green Planet Bioengineering Co Ltd $ 12 - $ 0 -
Inhibikase Therapeutics Inc $ 11 $ 0 $ -19 -
Sorrento Therapeutics Inc $ 10 - $ 0 -
Aptose Biosciences Inc $ 10 - $ -49 -
Organovo Holdings Inc $ 9 $ 0 $ -19 -
Biocardia Inc $ 8 $ 1 $ -13 -
Old Ayala Inc $ 8 $ 1 $ -38 -
Creative Medical Technology Holdings Inc $ 8 $ 0 $ -10 -
Allena Pharmaceuticals Inc. $ 8 - $ -43 -
Enzon Pharmaceuticals inc $ 6 $ 2 $ 1 -
Rubius Therapeutics Inc $ 5 - $ -180 -
Nanostring Technologies Inc $ 5 $ 162 $ -166 721
Fresh Tracks Therapeutics Inc $ 5 $ 10 $ -6 -
Finch Therapeutics Group Inc $ 4 $ 1 $ -100 -
Avalon Globocare Corp $ 4 $ 1 $ -9 -
Qrons Inc $ 3 - $ -2 -
Eloxx Pharmaceuticals Inc $ 3 - $ -32 -
Aceragen Inc $ 3 - $ -41 -
Palisade Bio Inc $ 3 - $ -13 -
Peak Bio Inc $ 2 - $ -26 -
Clarus Therapeutics Holdings Inc. $ 2 $ 8 $ -23 -
Kiromic Biopharma Inc $ 2 - $ -23 -
Windtree Therapeutics Inc $ 2 $ 1 $ -25 -
Codiak Biosciences Inc $ 1 $ 34 $ -17 -
Sqz Biotechnologies Company $ 1 - $ 0 -
Polarityte Inc $ 1 $ 3 $ -8 -
Tc Biopharm holdings Plc $ 1 $ 4 $ -1 -
Ladrx Corporation $ 1 - $ 1 -
Organicell Regenerative Medicine Inc $ 0 $ 5 $ -7 -
Cannabis Global Inc. $ 0 $ 4 $ -4 -
Genocea Biosciences Inc $ 0 $ 21 $ -37 -
Point Of Care Nano technology Inc $ 0 - $ 0 -
Spk Acquisition Corp - - $ -1 -
Biontech Se - $ 540 $ 11,528 1,700
Coeptis Therapeutics Holdings Inc - - $ -57 -
Anavex Life Sciences Corp - $ 3 $ -43 -
Forma Therapeutics Holdings Inc. - - $ -190 -
Agentix Corp - - $ -1 2
10x Capital Venture Acquisition Corp Iii - - $ -1 -
Mosaic Immunoengineering Inc - - $ -1 -
Biomx Inc - - $ 27 -
Fennec Pharmaceuticals Inc - $ 13 $ -20 -
Replicel Life Sciences Inc - - $ -1 -
Calidi Biotherapeutics Inc - - $ -29 -
Biondvax Pharmaceuticals Ltd - - $ -1 -
Biotechnology & Pharmaceuticals Industry $ 558,836 $ 90,441 $ 3,925 76,397
  Recent News from Biotechnology & Pharmaceuticals Industry
Financing Agreement

Outlook Therapeutics Closes Private Placement, Raising Up to $159 Million for Ophthalmic Bevacizumab Treatment



Iselin-based biopharmaceutical company, Outlook Therapeutics, has successfully concluded its private placement, securing upfront gross proceeds of approximately $60 million. In addition, the company has the potential to further bolster its financial position with up to $99 million upon the exercise of warrants issued in the private placement. Th...

Cyclo Therapeutics Inc

CYTH Sees Impressive Revenue Surge and Deficit Reduction in Q4 2023

Cyclo Therapeutics Inc, a Biotechnology and Pharmaceuticals company, has shown positive growth in the fourth quarter of 2023, despite industry-wide challenges. In its December 31, 2023 report, the company reported a significant revenue rise of 66.699% to $0.31 million. This increase in revenue has helped the company reduce its losses to $-0.18 per share, ...

Partnership

Celebrating a New Era of Automotive Excellence: Bentley Motors Receives Warrant of Automotive Distinction from the McWhorter Family Trust

In a groundbreaking announcement, the McWhorter Family Trust has forged a strategic partnership with Bentley Motors, marking a significant milestone in the realm of automotive excellence. Recognizing Bentley's unrivaled dedication to luxury, innovation, and craftsmanship, the Trust has bestowed the prestigious emblem of automotive distinction upon the ren...

Product Service News

Scilex Holding Company Advances ELYXYB Patent Approval in Canada While Preparing for Gloperba Launch and Expanding Distribution Network.

Scilex Holding Company Addresses Product Composition Questions for ELYXYB Patent in Canada, While Preparing for the Launch of Gloperba and Expanding Its Distribution NetworkPALO ALTO, Calif., March 18, 2024 ?? Scilex Holding Company (Nasdaq: SCLX), a revenue-generating company focused on non-opioid pain management products, has provided responses to Healt...

Clinical Study

Aligos Therapeutics Ventures into Phase 2a HERALD Study for Potential MASH Treatment, Provides Hope for Patients with Unmet Medical Needsnnn

Aligos Therapeutics, a prominent clinical stage biopharmaceutical company, has recently announced the initiation of the Phase 2a HERALD study of ALG-055009 in subjects with metabolic dysfunction-associated steatohepatitis (MASH). The study aims to address the unmet medical needs in liver and viral diseases and is a significant step for Aligos in developin...

Product Service News

Bluebird Bio Secures Debt Financing to Support Commercial Launches of Innovative Gene Therapies

Bluebird Bio Secures Debt Financing to Support Commercial Launches of Gene TherapiesBluebird Bio, a leading biotechnology company, has announced that it has secured a $175 million five-year term loan facility with Hercules Capital. This debt financing will strengthen the company's balance sheet as it focuses on the commercial launches of its three FDA-app...

Management Changes

Ocugen Inc. Appoints Dr. Huma Qamar as Chief Medical Officer Amidst Strong Market Performance and Promising Growth Prospects


In a strategic move to strengthen its position in the biotechnology industry, Ocugen Inc. (NASDAQ: OCGN) has recently appointed Dr. Huma Qamar as its new Chief Medical Officer (CMO). The addition of Dr. Qamar to the Ocugen team is expected to further accelerate the company's mission of discovering, developing, and commercializing innovative gene and ...

Calidi Biotherapeutics Inc

Calidi Biotherapeutics Inc Reports Operating Deficit of $-18.2 Million in Fourth Quarter of 2023

In the world of biotechnology and pharmaceuticals, Calidi Biotherapeutics Inc has recently announced its financial results for the fourth quarter of 2023. The company reported an operating deficit of $-18.246049 million, a significant increase from the operating deficit of $-2.714765 million in the fourth quarter of 2022.
The net deficit for the finan...

Coherus Biosciences Inc

Coherus Biosciences Inc Makes Bold Strategic Move in Divesting Ophthalmology Franchise for $170 Million

Coherus Biosciences, a leading biopharmaceutical company, has recently completed the divestiture of its Ophthalmology Franchise with an upfront cash payment of $170 million. This strategic move aims to strengthen the company's capital structure and focus on its core business areas.
The divestiture of Coherus' Ophthalmology Franchise is a significant s...

Fresh Tracks Therapeutics Inc

2. The Future of Fresh Tracks Therapeutics Inc: Analyzing Financial Results and Market Suspension

Fresh Tracks Therapeutics Inc: Navigating Challenges and Charting a New Course
As an investor and shareholder of Fresh Tracks Therapeutics Inc, I have closely followed the latest financial results and the recent announcement about the company's stock being suspended from trading on The Nasdaq Capital Market. As an avid reader of The , it is my pleasur...







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com